Rasilamlo
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rasilamlo, covering 2017-03-28 to 2017-03-28. Get the full timeline:
Most recent: EMA Withdrawn: Rasilamlo (aliskiren;amlodipine) — Novartis Europharm Ltd